On January 7, 2022, the Board of Directors of Absci Corporation, upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Dr. Joseph Sirosh to the Board effective that same date. Simultaneously with Dr. Sirosh's appointment, the size of the Board was fixed at seven directors and a third director position was added among the Class III directors. Dr. Sirosh will serve as a Class III director of the Company, to hold office until the Company's 2024 annual meeting of stockholders or until his earlier resignation, death, or removal.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.35 USD | +10.13% |
|
+19.51% | +3.57% |
Jul. 11 | KeyBanc Adjusts Price Target on Absci to $6 From $8, Maintains Overweight Rating | MT |
Jul. 03 | Morgan Stanley Initiates Absci at Overweight With $7 Price Target | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.57% | 447M | |
+25.83% | 46.56B | |
+45.38% | 41.67B | |
+0.69% | 41.16B | |
+30.52% | 32.4B | |
+22.30% | 28.18B | |
-6.35% | 28.1B | |
+49.25% | 14.52B | |
+49.18% | 13.74B | |
+3.45% | 12.17B |
- Stock Market
- Equities
- ABSI Stock
- News Absci Corporation
- Absci Corporation Announces Appointment of Joseph Sirosh to the Board